Multiple Sclerosis, Relapsing Forms
1 clinical trials · Condition
◉ Watch Multiple Sclerosis, Relapsing Forms
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis (NCT01585766) | MedImmune LLC | 2012-04-24 |
Track Multiple Sclerosis, Relapsing Forms automatically
Every clearance here is in the API, with alerts when new ones post.